Biocon share price jumped nearly 4 percent during early trades as the company received FDA approval for biosimilar drug Yesintek. Biocon touched intraday high of Rs 380 after opening at Rs 375.

Biocon Limited, a leader in biopharmaceuticals, captured investor attention today by trading within Rs 336.05 to Rs 355.45.

Biocon Ltd, a leading biopharmaceutical company, has been given an "Accumulate" rating by Geojit Financial Services with a target price of Rs. 376.

Biocon Stock closed 4 percent lower on Tuesday at Rs 375 compared to earlier close of Rs 390. The stock touched intraday high and low of Rs 395 and Rs 374 respectively.

Market expert Kushal Gupta has suggested four BUY Calls and no SELL Call for today’s trading session. Indian markets are expected to open lower today as global cues are negative.

Market expert Mitesh Thakkar has suggested four BUY Calls and no SELL Call for today's trading session.